(Q35591065)

9 August 2017

1 reference

title

Alternative routes of insulin delivery (English)

1 reference

9 August 2017

1 reference

Owens DR

1

1 reference

9 August 2017

Zinman B

series ordinal

2

1 reference

9 August 2017

Bolli G

series ordinal

3

1 reference

9 August 2017

publication date

1 November 2003

1 reference

9 August 2017

1 reference

9 August 2017

volume

20

1 reference

9 August 2017

issue

11

1 reference

9 August 2017

page(s)

886-898

1 reference

Insulins today and beyond

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01076.X

Insulin and C-peptide levels following oral administration of insulin in intestinal-enzyme protected capsules

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01076.X

Biologically erodable microspheres as potential oral drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01076.X

Oral tolerance for the treatment of autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01076.X

Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabète Insuline Orale group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01076.X

No effect of oral insulin on residual beta-cell function in recent-onset type I diabetes (the IMDIAB VII). IMDIAB Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01076.X

Phospholipid deformable vesicles for buccal delivery of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01076.X

Insulin across respiratory mucosae by aerosol delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01076.X

Pulmonary insulin administration using the AERx system: physiological and physicochemical factors influencing insulin effectiveness in healthy fasting subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01076.X

Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01076.X

Inhaled human insulin treatment in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01076.X

Dose-response relation of liquid aerosol inhaled insulin in type I diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01076.X

Intranasal insulin therapy: the clinical realities

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01076.X

10.1046/J.1464-5491.2003.01076.X

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference